Sangamo Therapeutics (SGMO) Tops Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts SGMO Hot Sheet
Price: $0.18 --0%
EPS Growth %: +25.0%
Financial Fact:
Loss from operations: -19.21M
Today's EPS Names:
CRMT, PKE, More
EPS Growth %: +25.0%
Financial Fact:
Loss from operations: -19.21M
Today's EPS Names:
CRMT, PKE, More
Join SI Premium – FREE
Sangamo Therapeutics (NASDAQ: SGMO) reported Q1 EPS of ($0.30), $0.01 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $28.2 million versus the consensus estimate of $27.29 million.
For earnings history and earnings-related data on Sangamo Therapeutics (SGMO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
- Morgan Stanley Resumes American Eagle Outfitters (AEO) at Equalweight
- Tepper’s Appaloosa soars 32% in H1 on prescient memory-chip bets - report
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
